1. Home >
  2. M&A >
  3. Buyout (LBO, MBO, MBI) >
  4. France >
  5. Keensight Capital Acquires BYG4lab

M&A Deal Summary

Keensight Capital Acquires BYG4lab

On July 22, 2022, private equity firm Keensight Capital acquired software company BYG4lab

Acquisition Highlights
  • This is Keensight Capital’s 5th transaction in the Software sector.
  • This is Keensight Capital’s 24th transaction in France.

M&A Deal Summary
Date 2022-07-22
Target BYG4lab
Sector Software
Buyer(s) Keensight Capital
Deal Type Buyout (LBO, MBO, MBI)

Target

BYG4lab

L'Union, France
BYG4lab is a software publisher specializing in medical biology middleware solutions. The Company provides a number of key benefits, including but not limited to: improving workflow management, making instrument integration more efficient, handling mega lab configuration, designing personalized dashboards, maximizing automatic validation, and managing quality control. The Company addresses both Central Lab and Point of Care testing, as well as all disciplines in the field of medical biology – immunochemistry, hematology, molecular, microbiology. BYG4lab was founded in 1982 and is based in L'Union, France.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Keensight Capital

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2000
PE ASSETS 5.5B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Keensight Capital is a private equity investment firm focused on majority and minority growth capital investments in Western European companies. Keensight makes equity investments in a number of situations including the provision of capital to finance growth, either organically or through acquisitions, or the buying out of existing shareholders. The Firm looks to invest €10 to €600 million and will consider business with up to €400 million in revenue. Keensight Capital was formed in 2000 and is based in Paris.

DEAL STATS #
Overall 38 of 53
Sector: Software M&A 5 of 10
Type: Buyout (LBO, MBO, MBI) M&A Deals 15 of 19
Country: France M&A 24 of 26
Year: 2022 M&A 5 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-21 Lisam Systems

Ecaussinnes, Belgium

Lisam Systems is a global provider of Environmental, Health and Safety (EH&S) compliance management software solutions and services, addressing more than 2,000 clients operating across various industries worldwide, including chemicals, detergents, paints and coatings, industrial and specialty gases, and fragrances. Lisam Systems was founded in 1999 and is based in Ecaussinnes, Belgium.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-07-28 Axxam

Bresso, Italy

Axxam is an iPRO (innovative Partner Research Organization) and discovery company located in the scientific campus OpenZone. The Company is a provider of discovery services for the entire life sciences industry. Axxam has strong expertise across a broad range of discovery disciplines and innovative technologies, including assay development, compound management, HTS (high-throughput screening) / HCS (high content screening), hit identification and hit validation. Axxam is also engaged in developing novel innovative therapies for diseases with a high unmet medical need. Axxam was founded in 2001 and is based in Bresso, Italy.

Buy -
Mergr

Solution for

Product

Company

Legal